| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.071 | 0.1 |